Albert J. Augustin, MD, On Combination Therapy Against Choroidal Neovascularization (CNV)

Dr. Albert J. Augustin from the University of Mainz in Germany discusses treatment strategies against choroidal neovascularization (CNV) in a conversation with retina specialist, Dr. Sophie Bakri. Dr. Augustine defines the combination therapy parameters currently in use at his institution to combat CNV.

His version of triple therapy consists of a modified photodynamic therapy (with reduced light dose of 73 seconds from 80) followed by an intravitreal injection of dexamethasone (800 mcg) and Avastin (2mg). In lesions that are somewhat fibrotic, 1mg of triamcinolone is added. They no longer do (Read more...)

Full Story →